StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Macquarie

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byMacquarieHorizon: NA (inferred 1 year)7 Oct 2026via Zee Business (Live)

Entry₹1,208Inferred
Target₹1,375
Total upside +13.82%
Stop lossNot given
CMP₹1,1803h ago
Active-2.32%+16.53%upside left 12 mo left
Follow Macquarie for new callsGet alertsWatch DRREDDY for new buy/sell callsGet alertsSee 16 other Long-term calls on DRREDDYSee 105 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:54 pm IST
12 supporting8 neutral10 opposing
Supports the BUY call (12)

Citi raises target for Dr Reddy's Laboratories stock to INR 1,450

NewsGoogle News·2 Oct · 6d ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade to Buy

NewsGoogle News·1 Oct · 1w ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade as margins face a test

NewsGoogle News·30 Sept · 1w ago

(opens in new tab)

8 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·29 Sept · 1w ago

Hikma signs exclusive licensing and distribution agreement with Dr. Reddy’s Laboratories for Nicotinell across MENA

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (8)

Q2 FY27 results scheduled — board meets 23 Oct 2026

BSE · Board Meeting·In 14 days

(opens in new tab)
Weighs against the BUY call (10)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·7 Oct · yesterday

Dr. Reddy's faces securities fraud probe after Q1 earnings hit by semaglutide batch issues.

NewsGoogle News·25 Sept · 2w ago

(opens in new tab)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·25 Sept · 2w ago

(opens in new tab)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 4w ago

(opens in new tab)

5 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·23 Jul · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Macquarie

Every call and its outcome